Shukra Pharmaceuticals Ltd

NSE: SHUKRAPHAR · BSE: 524632 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹69.70
Market cap: ₹3,064 Cr
Revenue (annual): ₹56.73 Cr
Net profit (annual): ₹22.06 Cr
P/E (TTM): 90.2×Sector 47.4×
Promoter holding: 51.15%+0.19% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 5 Other Announcement 4 Board Meeting Date 4 Financial Results 3 Fund Raise 2 Capital Structure Change 2 Board Meeting Outcome 2 SME to Main Board Migration 1 Merger & Restructuring 1 Management Change 1 Dividend 1 Debt & Borrowing 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

2 Sep 2026 18:49 IST BSE

Capital Structure Change

Shukra Pharmaceuticals Capital Structure Change

Shukra Pharmaceuticals allotted 11,73,000 equity shares following the conversion of warrants, generating Rs.3.13 Crore in exercise proceeds. This allotment increases the company's paid-up equity capital.

Value: ₹3.13 Cr

Read the filing ↗

14 Jul 2026 19:36 IST BSE

Capital Structure Change

Shukra Pharmaceuticals Capital Structure Change

Shukra Pharmaceuticals confirmed receipt of Rs. 0.38 Crore differential consideration for 46.43 lakh warrants. The price was revised from Rs. 34.00 to Rs. 35.56 per warrant.

Value: ₹0.38 Cr

Read the filing ↗